2026 FDA Peptide Reclassification Purefico Medspa and Therapy HHS Secretary RFK Jr. just dropped major news: the FDA is removing 12 peptides from its restrictive Category 2 list reversing the 2023 crackdown that shut down compounding pharmacies and fueled Deep Dive: Regulatory Status of Popular Compounded Peptides Holt Law An important update for anyone following the peptide space. While these compounds are still under evaluation and not FDA approved, this shift signals growing momentum toward clinician guided peptide research. Stay informed, stay FDA has removed certain bulk drug substances that were placed on the category two list and has announced it will consult the Pharmacy Compounding Advisory Committee (PCAC) for potential future inclusion of A Note on Peptides by Shantanu Out of Singapore